FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the chemical-pharmaceutical industry and represents a packed solid drug form of sufentanil, which includes an internal package, containing the solid drug form of a medication sufentanil and an oxygen absorber, as well as a method of preventing oxidative degradation of the solid drug form of sufentanil.
EFFECT: invention provides the reduction or elimination of oxidative degradation products in sufentanil-containing drug forms, increasing their stability.
25 cl, 12 tbl, 3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONCENTRATE OF THERAPEUTIC SOLUTION | 2011 |
|
RU2576026C2 |
| COMPOSITIONS OF STABLE TIACUMICINES | 2008 |
|
RU2484829C2 |
| SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUBSTITUTED INDANE, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2772693C1 |
| PACKAGED PRODUCT OF SOLID PREPARATION CONTAINING 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE, OR ITS SALT, OR ITS HYDRATE | 2014 |
|
RU2642670C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MIRTAZAPIN SALT | 2005 |
|
RU2375362C2 |
| STABILIZED PHARMACEUTICAL COMPOSITIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | 2014 |
|
RU2702345C2 |
| DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
| PHARMACEUTICAL COMPOSITIONS OF KETOROLAC | 2017 |
|
RU2677663C1 |
| DEVICE FOR CONTROLLING RELATIVE MOISTURE | 2005 |
|
RU2401451C2 |
| STABLE COMPOSITION OF INSULIN GLULISIN | 2014 |
|
RU2691059C2 |
